Another caveat is that CXCL13 expression is altered in response to infection, in cancer, systemic lupus erythematosus, rheumatoid arthritis, and other diseases involving germinal center, or ectopic lymphoid structure formation (113, 114). Here, CXCL13 is linked to systemic lupus erythematosus.